Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9139427 | 0.88 | TSHR (0.46) | TSHRMEN1KMT2ATHRBALDH1A1 | |
| SCHEMBL10393868 | 0.86 | TSHR (0.44) | TSHRMEN1KMT2ATHRBALDH1A1 | |
| SCHEMBL3635650 | 0.84 | MEN1 (0.33) | TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL15134519 | 0.81 | TSHR (0.44) | TSHRMEN1KMT2AALDH1A1TDP1 | |
| SCHEMBL1367526 | 0.76 | — | — | |
| SCHEMBL24587748 | 0.76 | TSHR (0.39) | TSHR | |
| SCHEMBL16826455 | 0.76 | TSHR (0.39) | TSHR | |
| SCHEMBL31578781 | 0.76 | TSHR (0.50) | TSHRALDH1A1 | |
| SCHEMBL24588713 | 0.76 | TSHR (0.39) | TSHR | |
| SCHEMBL10805593 | 0.75 | TSHR (0.38) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110128421-B | Simple preparation method of 5-halogenated-7-azaindole | 新发药业有限公司 | 2020-08-11 | — | — | CN | claimed |
| EP-4737436-A1 | CATIONIC LIPID CONTAINING TWO TERTIARY AMINE GROUPS, AND USE THEREOF | Xiamen Sinopeg Biotech Co., Ltd (CN) | 2026-05-06 | — | — | EP | disclosed |
| US-20250268828-A1 | Lipid Nanoparticle Compositions for Delivering Circular Polynucleotides | ORNA THERAPEUTICS, INC. | 2025-08-28 | — | — | US | disclosed |
| WO-2025104695-A1 | IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES THEREOF | Corti Therapeutics Pte. Ltd. (SG) | 2025-05-22 | — | — | WO | disclosed |
| CN-119698406-A | Nanomaterials comprising triols | 比姆医疗股份有限公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-119562942-A | Cationic lipid containing two tertiary amine groups and application thereof | 厦门赛诺邦格生物科技股份有限公司 | 2025-03-04 | — | — | CN | disclosed |
| WO-2025001700-A1 | CATIONIC LIPID CONTAINING TWO TERTIARY AMINE GROUPS, AND USE THEREOF | 厦门赛诺邦格生物科技股份有限公司 | 2025-01-02 | — | — | WO | disclosed |
| US-20240358841-A1 | NANOMATERIALS COMPRISING TETRAVALENT LIPID COMPOUNDS | BEAM THERAPEUTICS INC. | 2024-10-31 | — | — | US | disclosed |
| EP-4452930-A1 | IONIZABLE AMINE AND ESTER LIPIDS AND LIPID NANOPARTICLES | Beam Therapeutics Inc. (US) | 2024-10-30 | — | — | EP | disclosed |
| EP-4452942-A1 | NANOMATERIALS COMPRISING DISULFIDES | Beam Therapeutics Inc. (US) | 2024-10-30 | — | — | EP | disclosed |
| US-5162308-A | Pyrrole carbonitrile and nitropyrrole insecticidal, acaricidal and molluscicidal agents and methods for the preparation thereof | AMERICAN CYANAMID COMPANY (US) | 1992-11-10 | — | — | US | disclosed |
| EP-0486666-A1 | THERAPEUTIC HETEROCYCLIC COMPOUNDS. | WELLCOME FOUND (GB) | 1992-05-27 | — | — | EP | disclosed |
| WO-1991018897-A1 | THERAPEUTIC HETEROCYCLIC COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1991-12-12 | — | — | WO | disclosed |
| EP-0372263-A2 | Pyrrole carbonitrile and nitro-pyrrole insecticidal, acaricidal and molluscicidal agents and methods for the preparation thereof | AMERICAN CYANAMID COMPANY (US) | 1990-06-13 | — | — | EP | disclosed |
| EP-0363255-A1 | Analogues of 4-desoxydaunosamine, process for their preparation, anthracycline derivatives of these analogues and use of these anthracyclines as medicaments | LABORATOIRES HOECHST S.A. (FR) | 1990-04-11 | — | — | EP | disclosed |
| US-4855314-A | VASOCONTRICTORS, TREATMENT OF MIGRAINES, 3-(AMINO-ETHYL)-5-(PHENYL(ALKYL)-CARBONYL OR SULFONYL-AMINOALKYL SUBSTITUTED | GLAXO GROUP LIMITED (GB) | 1989-08-08 | — | — | US | disclosed |
| EP-0240096-A1 | Indole derivatives having a selective vasoconstrictor activity | GLAXO GROUP LIMITED (GB) | 1987-10-07 | — | — | EP | disclosed |
| EP-0050800-B1 | CARBOXYALKYL DIPEPTIDES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SCHERING CORPORATION (US) | 1986-06-18 | — | — | EP | disclosed |
| EP-0050800-A1 | Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them | SCHERING CORPORATION (US) | 1982-05-05 | — | — | EP | disclosed |
| US-4141915-A | REACTING AN UNSATURATED NITRILE, AN ALCOHOL, AND CARBON MONOXIDE | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) | 1979-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240358841-A1 | NANOMATERIALS COMPRISING TETRAVALENT LIPID COMPOUNDS | LCAT, PHOSPHO1, LIPC | TSHR 1236/4885MEN1 1288/4885KMT2A 2241/4885 |
| US-20250268828-A1 | Lipid Nanoparticle Compositions for Delivering Circular Polynucleotides | ABCB4, CETP, HDLBP | TSHR 3689/4885MEN1 4042/4885KMT2A 3198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.